Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prader-Willi Syndrome | 18 | 2024 | 67 | 5.960 |
Why?
|
Bariatric Surgery | 5 | 2022 | 114 | 1.550 |
Why?
|
Non-alcoholic Fatty Liver Disease | 10 | 2024 | 387 | 1.530 |
Why?
|
Gastrectomy | 4 | 2021 | 89 | 1.310 |
Why?
|
Fatty Liver | 6 | 2015 | 176 | 1.070 |
Why?
|
Pediatric Obesity | 5 | 2022 | 379 | 1.030 |
Why?
|
Obesity, Morbid | 5 | 2021 | 184 | 0.940 |
Why?
|
Larynx | 1 | 2024 | 69 | 0.850 |
Why?
|
Muscle Hypotonia | 1 | 2024 | 185 | 0.850 |
Why?
|
Obesity | 10 | 2020 | 2227 | 0.790 |
Why?
|
Bardet-Biedl Syndrome | 1 | 2022 | 38 | 0.790 |
Why?
|
Hypothalamic Diseases | 1 | 2022 | 37 | 0.770 |
Why?
|
Gastroenterology | 4 | 2020 | 191 | 0.760 |
Why?
|
Choline | 2 | 2012 | 55 | 0.760 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2020 | 224 | 0.720 |
Why?
|
Diet, High-Protein Low-Carbohydrate | 1 | 2020 | 1 | 0.710 |
Why?
|
Biological Clocks | 1 | 2020 | 28 | 0.700 |
Why?
|
Esophageal and Gastric Varices | 1 | 2020 | 64 | 0.690 |
Why?
|
Hypertension, Portal | 1 | 2020 | 78 | 0.670 |
Why?
|
Cecal Diseases | 1 | 2019 | 6 | 0.670 |
Why?
|
Child | 43 | 2024 | 24244 | 0.670 |
Why?
|
Hyperphagia | 5 | 2022 | 46 | 0.660 |
Why?
|
Cysts | 1 | 2019 | 100 | 0.630 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2020 | 314 | 0.630 |
Why?
|
Sleep Wake Disorders | 1 | 2020 | 177 | 0.590 |
Why?
|
Rectum | 1 | 2018 | 97 | 0.590 |
Why?
|
Self-Injurious Behavior | 1 | 2018 | 64 | 0.580 |
Why?
|
Gastroesophageal Reflux | 2 | 2020 | 289 | 0.570 |
Why?
|
Irritable Bowel Syndrome | 1 | 2020 | 205 | 0.570 |
Why?
|
Pediatrics | 5 | 2022 | 1139 | 0.550 |
Why?
|
Child Nutrition Sciences | 1 | 2016 | 19 | 0.540 |
Why?
|
Ascites | 4 | 2022 | 87 | 0.540 |
Why?
|
Sleep Apnea Syndromes | 2 | 2015 | 74 | 0.530 |
Why?
|
Humans | 78 | 2024 | 123184 | 0.530 |
Why?
|
Duodenum | 3 | 2020 | 98 | 0.510 |
Why?
|
Awards and Prizes | 1 | 2016 | 63 | 0.500 |
Why?
|
Choline Deficiency | 2 | 2012 | 4 | 0.500 |
Why?
|
Adolescent | 36 | 2024 | 19118 | 0.490 |
Why?
|
Hepatitis, Viral, Human | 1 | 2015 | 44 | 0.470 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2015 | 58 | 0.460 |
Why?
|
Metabolic Diseases | 2 | 2015 | 130 | 0.440 |
Why?
|
Infant | 20 | 2024 | 12347 | 0.410 |
Why?
|
Biliopancreatic Diversion | 1 | 2012 | 4 | 0.400 |
Why?
|
Dyslipidemias | 1 | 2015 | 229 | 0.400 |
Why?
|
Male | 41 | 2024 | 60083 | 0.400 |
Why?
|
Female | 45 | 2024 | 65494 | 0.390 |
Why?
|
Child, Preschool | 23 | 2024 | 13889 | 0.380 |
Why?
|
Child Health Services | 1 | 2012 | 86 | 0.380 |
Why?
|
Quality of Life | 1 | 2020 | 1932 | 0.360 |
Why?
|
Diet | 4 | 2013 | 1125 | 0.360 |
Why?
|
Giant Cells | 1 | 2010 | 34 | 0.360 |
Why?
|
Bile Ducts, Intrahepatic | 2 | 2010 | 95 | 0.360 |
Why?
|
Cholestasis, Intrahepatic | 2 | 2010 | 57 | 0.360 |
Why?
|
Intestinal Diseases | 1 | 2011 | 83 | 0.350 |
Why?
|
Hepatitis | 1 | 2010 | 59 | 0.350 |
Why?
|
Severity of Illness Index | 8 | 2024 | 2838 | 0.350 |
Why?
|
Food Hypersensitivity | 2 | 2015 | 149 | 0.340 |
Why?
|
Gastric Balloon | 1 | 2008 | 2 | 0.320 |
Why?
|
Feeding and Eating Disorders | 2 | 2012 | 70 | 0.310 |
Why?
|
Biopsy | 6 | 2020 | 1239 | 0.310 |
Why?
|
Weight Loss | 4 | 2022 | 478 | 0.310 |
Why?
|
Laparoscopy | 2 | 2016 | 501 | 0.300 |
Why?
|
Stomach Rupture | 1 | 2007 | 3 | 0.290 |
Why?
|
Necrosis | 2 | 2007 | 204 | 0.290 |
Why?
|
Protein-Energy Malnutrition | 1 | 2008 | 76 | 0.290 |
Why?
|
Dietary Supplements | 1 | 2011 | 472 | 0.290 |
Why?
|
Liver Diseases | 4 | 2017 | 362 | 0.280 |
Why?
|
Intestines | 1 | 2011 | 571 | 0.280 |
Why?
|
Nutrition Assessment | 4 | 2023 | 133 | 0.280 |
Why?
|
Nutritional Status | 4 | 2020 | 303 | 0.270 |
Why?
|
Hypertension | 1 | 2015 | 1287 | 0.270 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2020 | 1226 | 0.270 |
Why?
|
Liver | 5 | 2015 | 1734 | 0.260 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2007 | 187 | 0.260 |
Why?
|
Alanine Transaminase | 4 | 2020 | 151 | 0.260 |
Why?
|
Bile Duct Neoplasms | 1 | 2007 | 109 | 0.260 |
Why?
|
Cholangiocarcinoma | 1 | 2007 | 107 | 0.260 |
Why?
|
Hepatocytes | 2 | 2010 | 225 | 0.250 |
Why?
|
Body Mass Index | 6 | 2022 | 1541 | 0.250 |
Why?
|
Age Factors | 8 | 2020 | 2801 | 0.250 |
Why?
|
Airway Obstruction | 1 | 2007 | 164 | 0.240 |
Why?
|
Aging | 1 | 2012 | 1174 | 0.240 |
Why?
|
Gastric Bypass | 2 | 2021 | 69 | 0.240 |
Why?
|
Retrospective Studies | 15 | 2022 | 16022 | 0.240 |
Why?
|
Pancreatitis | 2 | 2017 | 130 | 0.240 |
Why?
|
Environmental Pollutants | 1 | 2024 | 68 | 0.220 |
Why?
|
Intubation, Gastrointestinal | 1 | 2024 | 52 | 0.220 |
Why?
|
Neoplasms | 2 | 2017 | 2772 | 0.220 |
Why?
|
Child Nutritional Physiological Phenomena | 2 | 2015 | 174 | 0.220 |
Why?
|
Nutritional Sciences | 2 | 2014 | 75 | 0.210 |
Why?
|
Deglutition Disorders | 1 | 2024 | 125 | 0.200 |
Why?
|
Education, Medical, Continuing | 2 | 2014 | 138 | 0.200 |
Why?
|
Cataplexy | 1 | 2022 | 1 | 0.200 |
Why?
|
North America | 4 | 2016 | 237 | 0.200 |
Why?
|
Narcolepsy | 1 | 2022 | 6 | 0.200 |
Why?
|
Hydrothorax | 1 | 2022 | 11 | 0.200 |
Why?
|
Enteral Nutrition | 1 | 2024 | 250 | 0.190 |
Why?
|
Adult | 14 | 2024 | 29065 | 0.190 |
Why?
|
Body Weight | 3 | 2023 | 999 | 0.190 |
Why?
|
Congenital Abnormalities | 1 | 2024 | 249 | 0.190 |
Why?
|
Hepatitis E | 1 | 2021 | 5 | 0.190 |
Why?
|
Disaccharidases | 1 | 2020 | 14 | 0.180 |
Why?
|
Ascitic Fluid | 1 | 2020 | 30 | 0.180 |
Why?
|
Lactase | 1 | 2020 | 41 | 0.180 |
Why?
|
Ambulatory Care Facilities | 1 | 2023 | 229 | 0.180 |
Why?
|
Serum Albumin | 1 | 2020 | 107 | 0.180 |
Why?
|
Sucrase-Isomaltase Complex | 1 | 2020 | 19 | 0.180 |
Why?
|
Liver Cirrhosis | 4 | 2022 | 823 | 0.180 |
Why?
|
Healthy Lifestyle | 1 | 2020 | 30 | 0.170 |
Why?
|
Vitamin E | 2 | 2011 | 64 | 0.170 |
Why?
|
Family Characteristics | 1 | 2020 | 78 | 0.170 |
Why?
|
Hepatic Encephalopathy | 1 | 2021 | 74 | 0.170 |
Why?
|
Carbohydrate Metabolism, Inborn Errors | 1 | 2020 | 36 | 0.170 |
Why?
|
Insulin | 4 | 2001 | 1198 | 0.170 |
Why?
|
Biopsy, Needle | 1 | 2000 | 229 | 0.170 |
Why?
|
Hepatomegaly | 1 | 1999 | 21 | 0.170 |
Why?
|
Migraine Disorders | 1 | 2021 | 64 | 0.170 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 118 | 0.170 |
Why?
|
Cecum | 1 | 2019 | 27 | 0.170 |
Why?
|
Exercise | 3 | 2022 | 810 | 0.170 |
Why?
|
DNA-Binding Proteins | 4 | 2001 | 2047 | 0.170 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 135 | 0.160 |
Why?
|
Fibrosis | 2 | 2012 | 429 | 0.160 |
Why?
|
Cystic Fibrosis | 2 | 2014 | 257 | 0.160 |
Why?
|
Mental Health Services | 1 | 2022 | 247 | 0.160 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 4 | 2001 | 20 | 0.160 |
Why?
|
Endpoint Determination | 1 | 2018 | 53 | 0.160 |
Why?
|
Metformin | 2 | 2011 | 146 | 0.150 |
Why?
|
Adolescent Nutritional Physiological Phenomena | 2 | 2015 | 33 | 0.150 |
Why?
|
Gastrointestinal Tract | 1 | 2020 | 208 | 0.150 |
Why?
|
Circadian Rhythm | 1 | 2020 | 269 | 0.150 |
Why?
|
Ultrasonography | 2 | 2019 | 941 | 0.150 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 134 | 0.150 |
Why?
|
Transcription Factors | 4 | 2001 | 2584 | 0.150 |
Why?
|
Hospitalization | 3 | 2021 | 1736 | 0.150 |
Why?
|
Cyclohexanes | 1 | 2017 | 8 | 0.150 |
Why?
|
Aminopeptidases | 1 | 2017 | 19 | 0.150 |
Why?
|
Epoxy Compounds | 1 | 2017 | 18 | 0.140 |
Why?
|
Appetite Depressants | 1 | 2017 | 22 | 0.140 |
Why?
|
Cinnamates | 1 | 2017 | 15 | 0.140 |
Why?
|
Sesquiterpenes | 1 | 2017 | 22 | 0.140 |
Why?
|
Patient Preference | 1 | 2018 | 116 | 0.140 |
Why?
|
Neutropenia | 2 | 2004 | 202 | 0.140 |
Why?
|
Registries | 1 | 2024 | 1393 | 0.140 |
Why?
|
Colonoscopy | 1 | 2019 | 239 | 0.140 |
Why?
|
Sleep | 1 | 2020 | 348 | 0.140 |
Why?
|
Quality Improvement | 1 | 2023 | 626 | 0.140 |
Why?
|
Mutation | 5 | 2007 | 5771 | 0.140 |
Why?
|
Protease Inhibitors | 1 | 2017 | 95 | 0.140 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2020 | 199 | 0.140 |
Why?
|
Attitude of Health Personnel | 3 | 2014 | 639 | 0.140 |
Why?
|
Societies, Scientific | 1 | 2016 | 26 | 0.140 |
Why?
|
Longitudinal Studies | 1 | 2020 | 1311 | 0.140 |
Why?
|
Hypoglycemic Agents | 2 | 2011 | 424 | 0.140 |
Why?
|
Nephrotic Syndrome | 1 | 2017 | 47 | 0.140 |
Why?
|
Vomiting | 2 | 2007 | 115 | 0.130 |
Why?
|
Medically Underserved Area | 1 | 2016 | 92 | 0.130 |
Why?
|
Feeding and Eating Disorders of Childhood | 1 | 2015 | 14 | 0.130 |
Why?
|
History, 21st Century | 1 | 2016 | 272 | 0.120 |
Why?
|
Surveys and Questionnaires | 4 | 2020 | 3670 | 0.120 |
Why?
|
United States | 6 | 2021 | 10632 | 0.120 |
Why?
|
Glycoproteins | 1 | 2017 | 369 | 0.120 |
Why?
|
Disease Management | 1 | 2019 | 515 | 0.120 |
Why?
|
Vulnerable Populations | 1 | 2016 | 140 | 0.120 |
Why?
|
Promoter Regions, Genetic | 4 | 2001 | 1336 | 0.120 |
Why?
|
Short Bowel Syndrome | 2 | 2014 | 59 | 0.120 |
Why?
|
Infant Formula | 1 | 2015 | 98 | 0.120 |
Why?
|
Young Adult | 6 | 2024 | 8885 | 0.120 |
Why?
|
Child Nutrition Disorders | 1 | 2015 | 76 | 0.120 |
Why?
|
Morbidity | 2 | 2021 | 241 | 0.120 |
Why?
|
Leadership | 1 | 2016 | 227 | 0.110 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2015 | 191 | 0.110 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 71 | 0.110 |
Why?
|
Craniopharyngioma | 1 | 2014 | 33 | 0.110 |
Why?
|
Nutritional Support | 1 | 2014 | 51 | 0.110 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 3379 | 0.110 |
Why?
|
Teicoplanin | 1 | 1993 | 3 | 0.110 |
Why?
|
Caregivers | 1 | 2018 | 574 | 0.110 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 1873 | 0.100 |
Why?
|
Professional Role | 1 | 2013 | 57 | 0.100 |
Why?
|
Infant, Newborn | 6 | 2021 | 8106 | 0.100 |
Why?
|
Administration, Oral | 3 | 2011 | 671 | 0.100 |
Why?
|
Malnutrition | 1 | 2015 | 196 | 0.100 |
Why?
|
Prevalence | 5 | 2020 | 2407 | 0.100 |
Why?
|
Research | 1 | 2014 | 263 | 0.100 |
Why?
|
Dietetics | 1 | 2012 | 19 | 0.100 |
Why?
|
Program Evaluation | 1 | 2014 | 449 | 0.100 |
Why?
|
Melena | 1 | 2011 | 5 | 0.100 |
Why?
|
Human Growth Hormone | 2 | 2011 | 74 | 0.100 |
Why?
|
Puberty | 1 | 2012 | 94 | 0.100 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2011 | 26 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2015 | 530 | 0.090 |
Why?
|
Postmenopause | 1 | 2012 | 125 | 0.090 |
Why?
|
Growth Charts | 1 | 2011 | 12 | 0.090 |
Why?
|
Arteriovenous Malformations | 1 | 2011 | 46 | 0.090 |
Why?
|
Nutritional Requirements | 1 | 2012 | 176 | 0.090 |
Why?
|
Digestive System Diseases | 1 | 2011 | 17 | 0.090 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 2010 | 9 | 0.090 |
Why?
|
Hypopituitarism | 1 | 2010 | 15 | 0.090 |
Why?
|
Liver Transplantation | 4 | 2000 | 1014 | 0.090 |
Why?
|
Societies, Medical | 4 | 2020 | 679 | 0.090 |
Why?
|
Treatment Outcome | 3 | 2022 | 12129 | 0.090 |
Why?
|
Cyclosporine | 4 | 1998 | 146 | 0.090 |
Why?
|
Fever | 1 | 1993 | 296 | 0.090 |
Why?
|
Alagille Syndrome | 1 | 2010 | 46 | 0.090 |
Why?
|
Parenteral Nutrition | 1 | 2011 | 183 | 0.090 |
Why?
|
Length of Stay | 4 | 2021 | 1285 | 0.080 |
Why?
|
Life Style | 2 | 2013 | 403 | 0.080 |
Why?
|
Cross Infection | 1 | 1993 | 332 | 0.080 |
Why?
|
Cytomegalovirus Infections | 1 | 2011 | 217 | 0.080 |
Why?
|
Pneumonia | 1 | 1993 | 325 | 0.080 |
Why?
|
Colon | 1 | 2011 | 353 | 0.080 |
Why?
|
Colitis, Ulcerative | 1 | 2011 | 208 | 0.080 |
Why?
|
Antioxidants | 1 | 2011 | 337 | 0.080 |
Why?
|
Jejunoileal Bypass | 1 | 2008 | 4 | 0.080 |
Why?
|
Prospective Studies | 4 | 2020 | 6034 | 0.080 |
Why?
|
Vagotomy | 1 | 2008 | 10 | 0.080 |
Why?
|
MEDLINE | 1 | 2008 | 20 | 0.080 |
Why?
|
Gastroplasty | 1 | 2008 | 10 | 0.080 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2008 | 32 | 0.070 |
Why?
|
Gastric Dilatation | 1 | 2007 | 3 | 0.070 |
Why?
|
Biliary Atresia | 1 | 2010 | 186 | 0.070 |
Why?
|
Television | 1 | 2008 | 71 | 0.070 |
Why?
|
Middle Aged | 4 | 2018 | 26002 | 0.070 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2008 | 159 | 0.070 |
Why?
|
Pilot Projects | 1 | 2011 | 1388 | 0.070 |
Why?
|
Disease Progression | 2 | 2024 | 2024 | 0.070 |
Why?
|
Immunosuppressive Agents | 3 | 1998 | 644 | 0.070 |
Why?
|
Clinical Competence | 1 | 2013 | 972 | 0.060 |
Why?
|
Baltimore | 2 | 2015 | 13 | 0.060 |
Why?
|
Body Composition | 1 | 2008 | 513 | 0.060 |
Why?
|
Cause of Death | 1 | 2007 | 458 | 0.060 |
Why?
|
Famotidine | 1 | 2005 | 9 | 0.060 |
Why?
|
Cohort Studies | 2 | 2012 | 4707 | 0.060 |
Why?
|
Double-Blind Method | 3 | 2017 | 1589 | 0.060 |
Why?
|
Health Education | 2 | 2020 | 225 | 0.060 |
Why?
|
Abdominal Pain | 1 | 2007 | 306 | 0.060 |
Why?
|
Halogenated Diphenyl Ethers | 1 | 2024 | 8 | 0.060 |
Why?
|
Tumor Cells, Cultured | 3 | 2001 | 1062 | 0.060 |
Why?
|
Histamine H2 Antagonists | 1 | 2005 | 49 | 0.060 |
Why?
|
Acute Kidney Injury | 1 | 2011 | 609 | 0.060 |
Why?
|
Clostridium perfringens | 1 | 2004 | 7 | 0.060 |
Why?
|
Forkhead Box Protein O1 | 2 | 2001 | 95 | 0.060 |
Why?
|
Intestinal Fistula | 1 | 2004 | 28 | 0.060 |
Why?
|
Sugars | 1 | 2023 | 15 | 0.060 |
Why?
|
Heart Failure | 1 | 2017 | 2131 | 0.060 |
Why?
|
Enteritis | 1 | 2004 | 54 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 1069 | 0.050 |
Why?
|
Gastrostomy | 1 | 2024 | 84 | 0.050 |
Why?
|
Aged | 3 | 2021 | 19088 | 0.050 |
Why?
|
Systems Analysis | 1 | 2023 | 14 | 0.050 |
Why?
|
Blood Pressure | 1 | 2008 | 1318 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2024 | 217 | 0.050 |
Why?
|
Transfection | 2 | 2001 | 1067 | 0.050 |
Why?
|
Forkhead Transcription Factors | 2 | 2001 | 368 | 0.050 |
Why?
|
Caustics | 1 | 2001 | 5 | 0.050 |
Why?
|
Binding, Competitive | 1 | 2001 | 179 | 0.050 |
Why?
|
Esophageal Stenosis | 1 | 2001 | 44 | 0.050 |
Why?
|
Gastroscopy | 1 | 2001 | 102 | 0.050 |
Why?
|
Esophageal Achalasia | 1 | 2001 | 35 | 0.050 |
Why?
|
Luminescent Proteins | 1 | 2001 | 157 | 0.050 |
Why?
|
Reference Values | 2 | 2013 | 696 | 0.050 |
Why?
|
Hemorrhage | 2 | 2004 | 459 | 0.050 |
Why?
|
Equipment Safety | 1 | 2000 | 37 | 0.050 |
Why?
|
Blood Coagulation Tests | 1 | 2000 | 60 | 0.040 |
Why?
|
Needles | 1 | 2000 | 51 | 0.040 |
Why?
|
Esophagoscopy | 1 | 2001 | 156 | 0.040 |
Why?
|
Hematocrit | 1 | 2000 | 110 | 0.040 |
Why?
|
Risk Factors | 3 | 2020 | 10021 | 0.040 |
Why?
|
High Mobility Group Proteins | 2 | 1997 | 32 | 0.040 |
Why?
|
Plasmids | 1 | 2001 | 510 | 0.040 |
Why?
|
Lipids | 1 | 2023 | 514 | 0.040 |
Why?
|
Clostridium Infections | 1 | 2004 | 238 | 0.040 |
Why?
|
Aspartate Aminotransferases | 1 | 2020 | 76 | 0.040 |
Why?
|
Microscopy, Fluorescence | 1 | 2001 | 330 | 0.040 |
Why?
|
Green Fluorescent Proteins | 1 | 2001 | 394 | 0.040 |
Why?
|
France | 2 | 2006 | 78 | 0.040 |
Why?
|
Radiography, Abdominal | 1 | 1999 | 47 | 0.040 |
Why?
|
Universities | 1 | 2020 | 126 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 1681 | 0.040 |
Why?
|
Genotype | 2 | 2020 | 2539 | 0.040 |
Why?
|
Blotting, Western | 1 | 2001 | 1101 | 0.040 |
Why?
|
Hemoglobins | 1 | 2000 | 300 | 0.040 |
Why?
|
Comorbidity | 2 | 2015 | 1498 | 0.040 |
Why?
|
Overweight | 1 | 2022 | 358 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2006 | 1262 | 0.040 |
Why?
|
Biomarkers | 2 | 2020 | 2942 | 0.040 |
Why?
|
Binding Sites | 1 | 2001 | 1291 | 0.040 |
Why?
|
Heterozygote | 1 | 2020 | 672 | 0.040 |
Why?
|
Methionyl Aminopeptidases | 1 | 2017 | 2 | 0.040 |
Why?
|
Health Care Costs | 1 | 2021 | 366 | 0.040 |
Why?
|
Early Termination of Clinical Trials | 1 | 2017 | 15 | 0.040 |
Why?
|
Phosphorylation | 1 | 2001 | 1610 | 0.040 |
Why?
|
Time Factors | 2 | 2020 | 6211 | 0.040 |
Why?
|
Blood Glucose | 2 | 2020 | 1114 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2017 | 56 | 0.040 |
Why?
|
Budd-Chiari Syndrome | 1 | 2017 | 7 | 0.040 |
Why?
|
Maryland | 1 | 2017 | 28 | 0.040 |
Why?
|
Inpatients | 1 | 2021 | 492 | 0.030 |
Why?
|
Rare Diseases | 1 | 2018 | 185 | 0.030 |
Why?
|
Seizures | 1 | 2022 | 871 | 0.030 |
Why?
|
Anxiety Disorders | 1 | 2022 | 677 | 0.030 |
Why?
|
Thailand | 1 | 2015 | 34 | 0.030 |
Why?
|
Physical Examination | 1 | 2017 | 164 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2008 | 3013 | 0.030 |
Why?
|
Recommended Dietary Allowances | 1 | 2015 | 23 | 0.030 |
Why?
|
Lactose | 1 | 2015 | 54 | 0.030 |
Why?
|
Venous Thrombosis | 1 | 2017 | 180 | 0.030 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2015 | 6 | 0.030 |
Why?
|
Calcifediol | 1 | 2015 | 13 | 0.030 |
Why?
|
Micronutrients | 1 | 2015 | 67 | 0.030 |
Why?
|
Milk Proteins | 1 | 2015 | 91 | 0.030 |
Why?
|
Databases, Factual | 1 | 2020 | 1169 | 0.030 |
Why?
|
Academies and Institutes | 1 | 2015 | 84 | 0.030 |
Why?
|
Dietary Carbohydrates | 1 | 2015 | 117 | 0.030 |
Why?
|
Radiography | 1 | 2017 | 818 | 0.030 |
Why?
|
Pregnancy | 2 | 2021 | 7146 | 0.030 |
Why?
|
Satiety Response | 1 | 2014 | 32 | 0.030 |
Why?
|
Health Personnel | 1 | 2019 | 499 | 0.030 |
Why?
|
Hypertriglyceridemia | 1 | 2015 | 100 | 0.030 |
Why?
|
Nuclear Proteins | 2 | 1997 | 1265 | 0.030 |
Why?
|
Hospitals | 1 | 2017 | 397 | 0.030 |
Why?
|
Dietary Fats | 1 | 2015 | 296 | 0.030 |
Why?
|
Behavior, Addictive | 1 | 2014 | 58 | 0.030 |
Why?
|
Age of Onset | 1 | 2015 | 581 | 0.030 |
Why?
|
Maple Syrup Urine Disease | 1 | 1993 | 15 | 0.030 |
Why?
|
Incidence | 1 | 2000 | 3050 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 826 | 0.030 |
Why?
|
Energy Intake | 1 | 2015 | 487 | 0.030 |
Why?
|
Brain Edema | 1 | 1993 | 67 | 0.030 |
Why?
|
Anxiety | 1 | 2018 | 956 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2012 | 98 | 0.020 |
Why?
|
Injections, Intravenous | 2 | 2005 | 252 | 0.020 |
Why?
|
Acute Disease | 1 | 2015 | 1092 | 0.020 |
Why?
|
Models, Animal | 1 | 2014 | 464 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 1999 | 2044 | 0.020 |
Why?
|
Eating | 1 | 2014 | 373 | 0.020 |
Why?
|
Parents | 1 | 2018 | 1033 | 0.020 |
Why?
|
Reproductive Health | 1 | 2012 | 44 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 382 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2020 | 2586 | 0.020 |
Why?
|
Cephalometry | 1 | 2011 | 33 | 0.020 |
Why?
|
Nutrition Disorders | 1 | 2011 | 32 | 0.020 |
Why?
|
Risk Assessment | 1 | 2020 | 3334 | 0.020 |
Why?
|
Data Collection | 1 | 2013 | 386 | 0.020 |
Why?
|
Odds Ratio | 1 | 2014 | 1243 | 0.020 |
Why?
|
Resuscitation | 1 | 1993 | 243 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 1993 | 452 | 0.020 |
Why?
|
Body Height | 1 | 2011 | 210 | 0.020 |
Why?
|
Health Behavior | 1 | 2013 | 381 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2009 | 101 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 2114 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2014 | 810 | 0.020 |
Why?
|
Niacinamide | 1 | 1989 | 24 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2014 | 764 | 0.020 |
Why?
|
Emulsions | 2 | 1998 | 65 | 0.020 |
Why?
|
Consensus | 1 | 2012 | 610 | 0.020 |
Why?
|
Chronic Disease | 1 | 2013 | 1167 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2014 | 695 | 0.020 |
Why?
|
Islets of Langerhans | 1 | 1989 | 173 | 0.020 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 1989 | 137 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2018 | 6376 | 0.020 |
Why?
|
Curriculum | 1 | 2013 | 719 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2011 | 1385 | 0.020 |
Why?
|
Sex Factors | 1 | 2011 | 1259 | 0.020 |
Why?
|
Polysomnography | 1 | 2008 | 137 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2011 | 335 | 0.020 |
Why?
|
Practice Patterns, Physicians' | 1 | 2013 | 711 | 0.020 |
Why?
|
HMGA1a Protein | 2 | 1997 | 4 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 1989 | 250 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2015 | 5050 | 0.020 |
Why?
|
Patient Selection | 1 | 2009 | 686 | 0.020 |
Why?
|
Research Design | 1 | 2009 | 686 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2005 | 141 | 0.010 |
Why?
|
Half-Life | 1 | 2005 | 156 | 0.010 |
Why?
|
Biological Availability | 1 | 2005 | 128 | 0.010 |
Why?
|
Inflammation | 1 | 2012 | 1402 | 0.010 |
Why?
|
Leukocyte Elastase | 1 | 2004 | 19 | 0.010 |
Why?
|
Area Under Curve | 1 | 2005 | 313 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 4227 | 0.010 |
Why?
|
Survival Rate | 2 | 1998 | 1996 | 0.010 |
Why?
|
Electroencephalography | 1 | 2008 | 862 | 0.010 |
Why?
|
Burns, Chemical | 1 | 2001 | 29 | 0.010 |
Why?
|
DNA | 2 | 1997 | 1592 | 0.010 |
Why?
|
Immunoblotting | 1 | 1999 | 312 | 0.010 |
Why?
|
Living Donors | 1 | 1998 | 112 | 0.010 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 1997 | 49 | 0.010 |
Why?
|
Hospital Costs | 1 | 1998 | 178 | 0.010 |
Why?
|
Oligonucleotides | 1 | 1997 | 88 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1998 | 533 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 2025 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 1999 | 766 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 1998 | 501 | 0.010 |
Why?
|
Leucine Zippers | 1 | 1995 | 17 | 0.010 |
Why?
|
Deoxyribonuclease I | 1 | 1995 | 49 | 0.010 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 1995 | 28 | 0.010 |
Why?
|
Tissue Donors | 1 | 1998 | 496 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 1998 | 1151 | 0.010 |
Why?
|
Protein Binding | 1 | 1997 | 1741 | 0.010 |
Why?
|
Base Sequence | 1 | 1997 | 3091 | 0.010 |
Why?
|
Pseudotumor Cerebri | 1 | 1993 | 58 | 0.010 |
Why?
|
Leucine | 1 | 1993 | 309 | 0.010 |
Why?
|
Rats, Inbred BB | 1 | 1989 | 5 | 0.010 |
Why?
|
Deferoxamine | 1 | 1989 | 7 | 0.010 |
Why?
|
NAD | 1 | 1989 | 48 | 0.000 |
Why?
|
Poly(ADP-ribose) Polymerase Inhibitors | 1 | 1989 | 28 | 0.000 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1997 | 935 | 0.000 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1989 | 150 | 0.000 |
Why?
|
Hyperplasia | 1 | 1989 | 210 | 0.000 |
Why?
|
Liver Neoplasms | 1 | 1997 | 1308 | 0.000 |
Why?
|
DNA Damage | 1 | 1989 | 506 | 0.000 |
Why?
|
Models, Biological | 1 | 1989 | 1441 | 0.000 |
Why?
|
Rats | 1 | 1989 | 3632 | 0.000 |
Why?
|
Animals | 1 | 1989 | 33714 | 0.000 |
Why?
|